Evidence map›Paper›PMID 20958075›Full record

ArticleThe Journal of organic chemistry2010

Total synthesis of (+)-nankakurines A and B and (±)-5-epi-nankakurine A.

Ryan A Altman, Bradley L Nilsson, Larry E Overman, Javier Read de Alaniz, Jason M Rohde, Veronique Taupin

Abstract read
In one paragraph

Article in The Journal of organic chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Neurotrophic natural products: chemistry and biology.Angewandte Chemie (International ed. in English) · 2014
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryan A AltmanDepartment of Chemistry, 1102 Natural Sciences II, University of California, Irvine, California 92697-2025, United States.
Bradley L Nilsson
Larry E Overman
Javier Read de Alaniz
Jason M Rohde
Veronique Taupin

Funding

SYNTHESIS OF ACTIVE NEUROLOGICAL AGENTSR01NS012389 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI OVERMAN, LARRY E. · 1985 to 2008
$3.3M
New Methods for the Synthesis of Neurological Agents and Other Heterocyclic MolecR01GM098601 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI OVERMAN, LARRY E. · 2011 to 2014
$1.6M
Asymmetric Pd(II)-catalyzed Ring-forming ReactionsF32GM085989 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI ALTMAN, RYAN A · 2008 to 2010
$127k
NIGMS NIH HHS 5F32GM085989NIGMS NIH HHS F32 GM085989NIGMS NIH HHS R01 GM098601NINDS NIH HHS NS-12389NINDS NIH HHS R01 NS012389
6 · The paper itself

Abstract

The first total syntheses of the Lycopodium alkaloids (+)-nankakurine A (2), (+)-nankakurine B (3), and the originally purported structure 1 of nankakurine A were accomplished. The syntheses of 2 and 3 feature a demanding intramolecular azomethine imine cycloaddition as the key step for generating the octahydro-3,5-ethanoquinoline moiety and installing the correct relative configuration at the spiropiperidine ring juncture. The cyclization precursor was prepared from octahydronaphthalene ketone 50, which was assembled from enone (+)-9 and diene 48 by a cationic Diels-Alder reaction. The Diels-Alder reactants were synthesized from 5-hexyn-1-ol (16) and (+)-pulegone (49), respectively. The tetracyclic ring system of 1 was generated using an unprecedented nitrogen-terminated aza-Prins cyclization cascade. The enantioselective total syntheses of (+)-nankakurine A (2) and (+)-nankakurine B (3) establish the relative and absolute configuration of these alkaloids and are sufficiently concise that substantial quantities of 2 and 3 were prepared for biological studies. (+)-Nankakurine A and (+)-nankakurine B showed no effect on neurite outgrowth in rat hippocampal H-19 cells over a concentration range of 0.3-10 μM.

Indexed as

AlkaloidsAnimalsCycloaddition ReactionHeterocyclic Compounds, Bridged-RingLycopodiumMolecular StructureRatsStereoisomerismAlkaloidsHeterocyclic Compounds, Bridged-Ringnankakurine Anankakurine B

Identifiers

PMID20958075
PMCPMC3038189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.